GoodRx: CFO Justin Fengler exercised 32,490 shares

What happened

• Justin Fengler, chief financial officer and chief strategy & operations officer, exercised or converted a derivative into 32,490 restricted stock units on Oct 15, 2026. The filing shows an acquisition entry for 32,490 shares (price N/A) and a separate derivative entry for 32,490 shares with a $0.00 price. The filing also shows 14,247 shares were surrendered to satisfy tax withholding at $3.38 per share for $48,155.

Key details

• Transaction date: Oct 15, 2026.
• Exercise/conversion: 32,490 restricted stock units (two derivative entries: one marked acquired at N/A, one marked disposed at $0.00).
• Tax withholding: 14,247 shares disposed at $3.38 per share for $48,155.
• Shares owned after the transaction: not reported in this filing.
• Footnotes: F1 — each restricted stock unit represents a contingent right to receive one share of Class A common stock; F2 — the restricted stock unit award vests 1/12 of the award in quarterly installments beginning Apr 15, 2026, subject to continued service.
• Filing date and report period: Oct 15, 2026; the report does not indicate a late filing.

Why it may matter

• The filing shows restricted stock units were converted and a portion of the resulting shares were surrendered to satisfy tax withholding (cashless tax withholding rather than a market sale).
• This filing does not show why the insider traded or why the company acted.